MARKER AND TARGET FOR RESPONSIVENESS AND RESISTANCE TO CANCER AGENTS

• 收藏
• 分享

专利权人:

发明人:

Lorraine ODriscoll,Sweta Rani

申请号：

US14352260

公开号：

US20140328840A1

申请日:

2012.10.22

申请国别(地区):

US

年份:

2014

代理人:

摘要：

An assay of identifying the responsiveness of a HER2-positive cancer in a patient to a HER2 targeted drug, the method comprising the step of comparing a level of NeuromedinU in a biological sample obtained from the patient with a reference level of NeuromedinU, wherein detection of a level of NeuromedinU that is increased compared to the reference level of NeuromedinU indicates that the HER2-positive cancer has reduced responsiveness to a HER2 targeted drug.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/